CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Genotech Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Genotech Corp
26-69, Gajeongbuk-ro, Yuseong-gu
Phone: +82 428628404p:+82 428628404 DAEJEON, 34113  South Korea Ticker: 066830066830
Business Summary
Genotech Corporation is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) & Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Jae JongKim
Director, Research MoonYoung-ho

General Information
Number of Employees: 28 (As of 12/31/2023)
Outstanding Shares: 5,667,180 (As of 12/31/2023)
Shareholders: 228
Stock Exchange: KON
Fax Number: +82 428628406


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024